Aktiesnakken — Oktober 2010
-
nej heller ikke EU
-
husk nu huntexil....
-
ja jeg holder over salgstal
-
johalan, det har en partner helt sikkert.
-
Nu har de et roadmap for zalutumumab, som overraskende indeholder DIREKTE filling i EU, hvilket ingen havde regnet med
-
det SKAL være over 100 mio i salg. Ellers er det en større skuffelse
-
Det er meget mere bullish end NS Huntexil fordi dette sker EFTER dialog med myndighederne
-
trold det passer simpelthen ikke og husk nu at bruge dollar !
-
18 mio dollar og omsætningen stiger 50%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind